EXPIRED: ONKONEK anticancer drug
SYNTHERIX Ltd is a new company this year in order to take ONKONEK, a totally new and different way of killing cancer but not normal cells, through preclinical animal studies with the CRUK Institute of Cancer Therapeutics.
£150,000 JUST INVESTED
Currently raising funds via Angel Investment Network.
Financials
| Raising: | £350,000 |
| Deadline: | 12-10-2023 |
The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested. Investors should carry out their own due diligence and take professional advice where necessary.
We act as an investment opportunity aggregator, collecting hundreds of investment opportunities from across the UK.
If you'd like your events, opportunities and news listed here please join free as an organisation.